Success Metrics

Clinical Success Rate

100.0%

Based on 6 completed trials

Completion Rate

100%(6/6)

Active Trials

0(0%)

Results Posted

17%(1 trials)

Phase Distribution

Ph not_applicable

43%

Ph phase_4

43%

Ph phase_3

14%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 3Large-scale testing

1(14.3%)

Phase 4Post-market surveillance

3(42.9%)

N/ANon-phased studies

3(42.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(6)

Other(1)

Detailed Status

Completed6

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 31 (14.3%)

Phase 43 (42.9%)

N/A3 (42.9%)

Trials by Status

completed686%

unknown114%

Recent Activity

0 active trials

Showing 5 of 7

completednot_applicable

Clinical Trials (7)

Showing 7 of 7 trials

NCT04878536Not Applicable

Efficacy Testing of Collagen Elixir

Completed

NCT04225091Not Applicable

Efficacy Evaluation of Triple up® Collagen Drink on Skin Condition

Completed

NCT02797249Phase 3

Low Dose Aspirin in the Prevention of Preeclampsia in China

Completed

NCT03419767Phase 4

Insulin Resistance in Patients After Carotid Revascularization

Unknown

NCT03115034Phase 4

Melatonin in Patients Under Carotid Endarterectomy

Completed

NCT02006836Not Applicable

Glycemic Responses to Majia Pomelos in Type 2 Diabetic Patients

Completed

NCT00935194Phase 4

Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1) : Multi-centre, Prospective, Randomized Controlled Study

Completed

All 7 trials loaded

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 7